Daniel I. Isaac

Transplant Surgery

100 Michigan Street Northeast
Suite MC269
Grand Rapids, MI 49503

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pancreatic Neuroendocrine Tumor in Lynch Syndrome: Expanding the Tumor Spectrum of Mismatch Repair Deficiency.

Pancreatic Neuroendocrine Tumor in Lynch Syndrome: Expanding the Tumor Spectrum of Mismatch Repair Deficiency.

Journal: Cureus

Published: June 06, 2026

HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

CRE26-050: Expanding Therapeutic Boundaries: Durable Remission of EBV-Positive NK/T-Cell Lymphoma With Pembrolizumab in the Setting of Renal Dysfunction.

CRE26-050: Expanding Therapeutic Boundaries: Durable Remission of EBV-Positive NK/T-Cell Lymphoma With Pembrolizumab in the Setting of Renal Dysfunction.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CRE26-050: Expanding Therapeutic Boundaries: Durable Remission of EBV-Positive NK/T-Cell Lymphoma With Pembrolizumab in the Setting of Renal Dysfunction.

CRE26-050: Expanding Therapeutic Boundaries: Durable Remission of EBV-Positive NK/T-Cell Lymphoma With Pembrolizumab in the Setting of Renal Dysfunction.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

EPR26-181: Racial and Ethnic Demographic Reporting in Studies Cited by the NCCN Testicular Cancer Guidelines: An Evidence Audit.

EPR26-181: Racial and Ethnic Demographic Reporting in Studies Cited by the NCCN Testicular Cancer Guidelines: An Evidence Audit.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Leukemia Cutis at Initial Diagnosis of Acute Myeloid Leukemia Consistent With Therapy-Related Disease After Lung Cancer Chemotherapy: A Case Report.

Leukemia Cutis at Initial Diagnosis of Acute Myeloid Leukemia Consistent With Therapy-Related Disease After Lung Cancer Chemotherapy: A Case Report.

Journal: Case reports in hematology

Published: September 16, 2025

A Trend Analysis of Metastatic Lung Cancer Disparities in the United States in the Era of Lung Cancer Screening.

A Trend Analysis of Metastatic Lung Cancer Disparities in the United States in the Era of Lung Cancer Screening.

Journal: Cureus

Published: May 31, 2025

Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment Centres.

Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment Centres.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 05, 2024

Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohort.

Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohort.

Journal: Blood vessels, thrombosis & hemostasis

Published: July 02, 2024

Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.

Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.

Journal: Biomedicines

Published: March 11, 2022

Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia.

Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia.

Journal: BMJ case reports

Published: August 28, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026